-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Minneapolis/St
When CISH fails, T cells are more effective at recognizing mutant proteins produced by tumors
Dr.
Since CISH resides within the cell, it cannot be suppressed
Dr Weber said: "This work is the culmination of a huge, multidisciplinary effort to include fundamental mechanisms of immunobiology, cutting-edge technology in genome editing, and recent advances in
Gene editing offers a powerful new tool that allows researchers to hard-connect checkpoint inhibition to specific immune cells that fight tumors, thereby accelerating the clinical translation
The research team continues clinical trials and is conducting related studies to evaluate the efficacy and safety of CISH-edited tumor-infiltrating lymphocytes